Moderna, Inc. (MRNA)
48.88
-0.16
(-0.32%)
USD |
NASDAQ |
May 18, 10:24
Moderna Profit Margin (Quarterly) : -345.2% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 21.02% |
| Biogen, Inc. | 13.29% |
| Gilead Sciences, Inc. | 28.94% |
| Arbutus Biopharma Corp. | 94.74% |
| AbbVie, Inc. | 4.58% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.61% |
| Return on Assets | -26.32% |
| Return on Invested Capital | -32.15% |
| Gross Profit Margin (Quarterly) | -160.7% |
| Operating Margin (Quarterly) | -356.8% |
| Return on Net Operating Assets | -87.00% |